Cohance Lifesciences Limited — Others, 26-03-2025: Trading Window

Suven Pharmaceuticals Limited has announced a board meeting on May 28, 2025, to consider and approve the financial results for the quarter and half-year ending March 31, 2025. The trading window for the company's securities will be closed from April 1, 2025, to May 30, 2025, as part of insider trading regulations. This meeting is crucial for assessing the company's financial performance and direction, which may influence investor sentiment. A strong financial report could foster a positive outlook among shareholders, while any disappointing results may pose potential risks to investor confidence.